Navigation Links
Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
Date:4/1/2008

Reflects Full Scope of Integrated Global Services

CAMBRIDGE, Mass., April 1, 2008 /PRNewswire/ -- Abt Associates Clinical Trials today launches under a new name, Abt Bio-Pharma Solutions, Inc., a wholly owned subsidiary of Abt Associates Inc. The company will continue to provide custom strategic, research and communication solutions for the pharmaceutical, biotechnology, medical device and diagnostics industries utilizing a team approach that blends decades of experience with wide ranging technical and therapeutic area expertise.

Abt Bio-Pharma Solutions (ABS) offers a wide range of integrated services across the product lifecycle, including health economics and outcomes research, registries and other real world studies, clinical trials, biometrics and marketing consulting and research. Experienced professional staff lead cross-functional teams that are better able to address the complex issues facing the bio-pharma industry. Sponsors find that this integrated, collaborative approach promotes cost- and time-effective solutions to their business problems, with the result that the organization has grown 30 percent over the past year.

"ABS helps sponsors achieve success for their products in a very competitive marketplace," said Steven Fosburg, Executive Vice President and Managing Director of ABS. "We will leverage the increased flexibility that our new organization affords to invest in staff and resources to meet the expanding needs of our global client base without sacrificing any of the scientific rigor or timeliness that we are known for." ABS will open an office in Basel, Switzerland in May 2008.

Abt Associates has been a leader in healthcare-related research since 1965. "Abt Associates has a strong commitment to improving the health of people and communities around the world," said Wendell J. Knox, President and CEO of Abt Associates. "Abt Bio-Pharma Solutions is well positioned to respond to the clinical research and
'/>"/>

SOURCE Abt Associates
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NSF International Acquires David Begg Associates
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
4. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
5. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
6. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes
7. Halogen Receives High Ratings from Bersin & Associates - Company recognized as a market leader, and receives praise for outstanding customer satisfaction
8. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
9. Lambert, Edwards & Associates Named Agency of Record for The West Michigan Science & Technology Initiative
10. QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...LOOMINGTON, Minn., Nov. 30 Acuo Te... image management software, data migration tools a...na Hospitals and Clinics for a new Vendor Neutral ...torage across the Allina network of hospitals, cli...is based on the Acuo Technologies DICOM Services G...
(Date:11/30/2009)...ICAGO, Nov. 30 Dr. Jessica Torrent...ington University Medical Center in Washington, D....-Specific Gamma Imaging (BSGI) in clinical practic... of breast cancer today at the annual meeting of t..., "The purpose of the exhibit was to demonstrat...
(Date:11/30/2009)..., SEATTLE, Nov. 30 Ce... announced today that its new class of platinum-ba...emonstrated a stronger anti-tumor potency and acti...d compounds as well as the ability to overcome cis...ts were presented in a paper titled "Novel Bis-pla...
(Date:11/29/2009)...se is available in German . , The concept o...n physics. The most famous example is that of quar...s. Now Prof. Bella Lake from Helmholtz-Zentrum Ber...sts report for the first time an experimental real...rved in a condensed matter system. , The concept...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2
...medica Corporation, an orthopedic implants company...announced today that it has received a CE (Conform...pinal intervertebral spacers using novel CSC (canc...chnology, made using Amedica,s novel silicon nitri...structure designed to promote bony fusion. , , ...
...evelop Powerful Tools for Detecting Ovarian Cancer...a., May 4 BD (Becton, Dickinson and Company) (NYS...ced today the signing of a worldwide development a.... , , Under the agreement, the two companies wi...jirebio Diagnostics, cancer biomarkers for use on ...
...ioTech Inc. (OTC Bulletin Board: PLMO; Frankfort B...the Chief Scientific Officer of its Pulmo Science ...d concept is to present a paper at the 5th Interna...09 to be held in Quebec, Canada from June 26th to ...nt of Radiolabeled Adrenomedullin Analogs Designed...
Other Biology Technology:Amedica Receives CE Mark for Valeo(TM) Ceramic Spinal Implant System Incorporating CSC Technology 2BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management 2BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management 3BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management 4Pulmo BioTech Inc. Announces Paper to be Presented at Symposium 2Pulmo BioTech Inc. Announces Paper to be Presented at Symposium 3
(Date:11/26/2009)...d for their impressive antlers, red deer have been...t a deer,s antlers are much more than decorative. ...when duelling. John Currey, from The University of...operties of bone for over half a century and has b...ntler through a long-standing collaboration with T...
(Date:11/26/2009)...(methicillin-resistant Staphylococcus Aureus ) an...ation as low-temperature plasma prototype devices ... unfailing bactericidal cocktails. , Two prototy...disinfection of healthy skin (e.g. hands and feet)... pose a lethal threat; and another to shoot bacter...
(Date:11/25/2009)... Sarit Larisch, Head of the Cell Death Research La...f Biology, has been awarded the prestigious Johnso... exploring the cause of brain cell damage in Parki...ear to scientists in support of innovation and exc...icially conferred earlier this month at an event a...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 1Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 3Studies Report More Harmful Effects From BPA 48481 1Studies Report More Harmful Effects From BPA 48481 2Studies Report More Harmful Effects From BPA 48481 3Zero tolerance alcohol policy good choice for parents 48478 1Zero tolerance alcohol policy good choice for parents 48478 2
...due University have built and demonstrated a proto... synthetic cell membranes in an effort to speed th..., including cancer. , The researchers created a c...ds of tiny vessels sitting on top of a material th...rial makes it possible to carry out reactions insi...
... the animal kingdom and beyond are characterized b...retches of DNA containing multiple genes that are ...ne reason for this broad gene silencing is the vit...nst unwanted recombinations of genetic material or...enomic instability, particularly in the regions at...
...MRI scan that measures the flow of water molecules...y in the course of brain cancer regimen if a patie...rchers at the University of Michigan Comprehensive...y call a functional diffusion map. They used a mag...sion, or movement, of water through the brain and ...
Other Biology News:Purdue proves concept of using nano-materials for drug discovery 2Purdue proves concept of using nano-materials for drug discovery 3Enzyme shown to help protect genomic stability 2New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 2New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 3
Sheep NP-SSA (Sheep Serum Albumin), Unconjugated from Biosearch Technologies
Label IT Tracker Fluorescien Intracellular Nucleic Acid Localization Kit from Mirus Bio Corporation
Anti-Human Aminopeptidase P2 / XPNPEP2 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Normal Rat Serum from Equitech-Bio
Biology Products: